Equites Radar

ALGN · Align Technology, Inc.

Medical Instruments & SuppliesUnited StatesAnalyst view: Buy

$167.02

+4.49% last session

End-of-day data · updated 2026-07-28

Mildly bullish3 bullish · 1 bearish technical signals
Consensus: Buy (1.88 from 14 analysts)
To mean target: +25.9%

Market cap

$12B

Enterprise value

$11B

Trailing P/E

28.2

Forward P/E

13.6

Dividend yield

Beta

1.67

Avg volume

1M

Employees

20K

2D change

5D change

-0.11%

10D change

-4.93%

30D change

-5.82%

60D change

-3.94%

MTD change

-7.41%

YTD change

7.62%

Analyst Outlook

Consensus ratingBuy
Recommendation mean (1–5)1.88
Covering analysts14
Mean price target$210.29
Low price target$175.00
Upside to mean target+25.9%

Analyst estimates change daily — follow the shifts on the Estimate Trends page.

Technical Analysis

RSI (14)50.2
50-day MA$172.59
200-day MA$165.86
Price vs 50-day MA+1.7%
Price vs 200-day MA+5.9%
MACD histogram-1.14
Volume vs 3-month avg0.9×
52w low $124.8852w high $207.19

Analyst sentiment over time — ALGN

Rec Mean (blue, left — higher = more bullish) vs. price targets (right).

Investment Bank Ratings as of 2026-07-09

Latest call per bank · past 12 months

Morgan Stanley

Equal-Weight

$188

+12.6% vs price
▲ raised from $169Maintains · 2026-04-24

Citigroup

Buy

$240

+43.7% vs price
▲ raised from $0.00Initiates · 2026-04-15

Barclays

Overweight

$200

+19.7% vs price
Upgrade · 2026-03-17

HSBC

Buy

$200

+19.7% vs price
▲ raised from $150Upgrade · 2026-02-09

UBS

Neutral

$185

+10.8% vs price
▲ raised from $175Maintains · 2026-02-05

Wells Fargo

Overweight

$200

+19.7% vs price
▲ raised from $181Maintains · 2026-02-05

Jefferies

Hold

$140

-16.2% vs price
▼ cut from $215Downgrade · 2025-10-10

Recent rating actions

DateFirmActionRatingPrice target
2026-07-09BMO CapitalInitiatesOutperform$0.00 $209
2026-04-30Evercore ISI GroupMaintainsOutperform$200 $220
2026-04-24Morgan StanleyMaintainsEqual-Weight$169 $188
2026-04-21Piper SandlerMaintainsOverweight$220 $235
2026-04-15CitigroupInitiatesBuy$0.00 $240
2026-03-17BarclaysUpgradeEqual-WeightOverweight$200
2026-02-26BarclaysMaintainsEqual-Weight$170 $200
2026-02-09HSBCUpgradeHoldBuy$150 $200

Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.

Signal Summary as of 2026-07-28

  • RSI (14): RSI is 50 — neutral momentum, neither overbought nor oversold.
  • Price vs 50-day MA: Trading 1.7% above the 50-day MA ($172.59).
  • Price vs 200-day MA: Trading 5.9% above the 200-day MA ($165.86).
  • MA cross: The 50-day MA sits above the 200-day MA (golden-cross regime) — the longer-term trend points up.
  • MACD (12,26,9): MACD histogram is negative (-1.14) — short-term momentum is fading.
  • 52-week range: Price sits between the 52-week low ($124.88) and high ($207.19).

ALGN Price Chart

Loading chart for ALGN

Fundamentals

Revenue (TTM)$4.0B
EBITDA$1.0B
Free cash flow$1.0B
Operating cash flow$1.0B
Book value / share$57.94
Net debt / EBITDA-1.1
WACC15.0%
Revenue growth6.00%
Earnings growth24.00%

About Align Technology, Inc.

Align Technology, Inc. provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers Invisalign comprehensive package to treat adults and teens malocclusion and features, and orthodontic needs of teenage or younger patients; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients between the ages of six and ten years with a mixture of primary/baby and permanent teeth. This segment also provides Invisalign express, Invisalign lite, and Invisalign moderate; Invisalign Go, Invisalign Go express, and Invisalign Go Plus; retention products, Invisalign training, adjusting tools used by dental professionals during treatment, ancillary Invisalign accessory products, and other oral health products; Invisalign Professional Whitening system; Invisalign Palatal Expander, a 3D printed orthodontic device; and 3D printing solutions. Its Imaging Systems and CAD/CAM Services segment offers iTero intraoral scanning system, a single hardware platform for restorative or orthodontic procedures; exocad, a computer-aided design and computer-aided manufacturing software; orthodontist software for digital records storage, orthodontic diagnosis, and fabrication of printed models and retainers; and restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons. This segment also offers Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; Align Oral Health Suite, a digital interface for dental consultations; iTero TimeLapse technology for doctors or practitioners to compare a patient's historic 3D scans to the present-day scan; and subscription software, disposables, rents scanners, and pay per scan services. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.

More in Medical Instruments & Supplies

Screen ALGN against the full market on the Radar →

Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.